Sulphasalazine: An alternative drug for second-line treatment of juvenile chronic arthritis

Advances in Experimental Medicine and Biology

Volumn 455, Issue , 1999, Pages 331-336

  Varbanova, B B ^a   Dyankov, E D ^a  

^a MEDICAL UNIVERSITY OF VARNA   (Bulgaria)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; ANTIRHEUMATIC AGENT; AZATHIOPRINE; SALAZOSULFAPYRIDINE; STEROID;

ADOLESCENT; ADULT; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG TOLERANCE; FEMALE; HUMAN; JUVENILE RHEUMATOID ARTHRITIS; MALE; NEUTROPENIA; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0033282356     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4615-4857-7_50     Document Type: Conference Paper

References (23)

1. Rheumatoid arthritis: A risk factor for sulphasalazine toxicity? A meta-analysis
2. Outcome of second line therapy in rheumatoid arthritis
3. Sulphasalazine in rheumatoid arthritis: Long term tolerability in 432 patients monitored for 2 to 15 years
4. Long term experience with sulphasalazine in a cohort of early rheumatoid arthritis patients
5. Long term second-line treatment: A prospective drug "survival" study
6. Use of short-term efficacy/ toxicity trade- offs to select second-line drugs in rheumatoid arthritis. A metaanalysis of published clinical trials
7. Sulphasalazine in the treatment of juvenile rheumatoid arthritis: A preliminary open trial
8. Sulphasalazin bei juveniler chronischer Arthritis
9. Multicentre pilot study of sulphasalazine in juvenile chronic arthritis
10. Juvenile rheumatoid arthritis
11. Guidelines for the management of rheumatoid arthritis
12. Effects of sulphasalasine on antigen specific and IL2 -dependent proliferation of human T cell lines and clones
13. Sequential study of bacterial antibody levels and faecal flora in rheumatoid arthritis patients taking sulphasalazine
14. The ethiological role of reactive arthritis-associated bacteria in pauciarticular juvenile chronic arthritis
15. The role of infection in chronic arthritis
16. Guidelines for monitoring of drug therapy in rheumatoid arthritis
17. Disease activity in rheumatoid arthritis: Preliminary report of the consensus study group of the European Workshop for Rheumatology Research
18. The variations of clinical measurements
19. OMERACT conference on outcome measures in rheumatoid arthritis clinical trials: Introduction
20. Redundancy of the conventional outcome variables used in juvenile rheumatoid arthritis clinical trials
21. Treatment of juvenile arthritis with sulphasalazine
22. Sulphasalazine treatment in juvenile chronic arthritis: An open study
23. Sulphasalazine and Delagil- A comparative study in patients with juvenile chronic arthritis